EXAS April options mis-priced

EXAS:

I sold 1 (one) April $7 put for $45.

I'll take 100 shares at $7. If there's a problem they can probably fix it... and if they can't somebody else (e.g. BMS) can buy them and maybe THEY can fix it. Either way it will be a long time before the whole story is told.

BTW: Implied Volatility really is that high.

You bought the shares outright???

WOW... that's against my religion. I sold an Oct $10 put for $270.


http://www.reuters.com/article/2013...News&feedType=RSS&feedName=companyNews&rpc=43

so my April $7 put will produce a 7 - .45 = 6.55 acquisition price
while my Oct $10 put will produce a 10 - 2.70 = 7.3 acquisition price.

Currently I am showing a premarket price of 6.68 . I got my 'cover' notice from Optionsxpress.

If we open at 6.68 my net loss will be $49. This is why I don't plunge into this kind of situation.

I think this is a good result, but the people who DO plunge are mostly a bunch of amateurs who are now in a panic.

I may just take the 200 shares and wait.
:-)
 
Quote from newwurldmn:

I added more shares as well.

So this is my net position. I've seen this story before. I believe the trial will work, but the upside is limited. The Downside however is pretty bad.

It's not impossible the stock will selloff after a successful result (as fast money dumps in search of another catalyst stock to own).

There's a lot of optimism here. Even Cramer is touting the shares.

I thought at the time that in the midst of all the euphoria, you were taking a pragmatic view in terms of risk management.

The reaction of the market to the data release proves your caution was justified.
 
Quote from justrading:

I thought at the time that in the midst of all the euphoria, you were taking a pragmatic view in terms of risk management.

The reaction of the market to the data release proves your caution was justified.

Thanks. But a loss is a loss.
 
Interesting market reaction to EXAS study. Market reaction is negative
on interpretation not data. Namely, only 42% versus 57% result, as
found by previous study, detetection of pre-cancer polyps up to 1 cm. 2cm
targeted 67% sensitivity (ability to find) was reached.

EXAS President was just on CNBC so I think pre-market fall will be partially
reversed so EXAS might be good for traders. I think he is right that the
test will be approved by the FDA and used because there is nob alternative
even close.

Multi-strike short naked puts (some as naked puts some as covered calls) works.
I now hope EXAS stock will close tomorrow at 8.99 so I get maximum numbers
of shares. My overall share cost will be around 7.50. Pin to 9.00 means I
get the shares with some profit and least use of IB margin for a large position.

I think market reaction is irrational but as a purely fundamental value trader
there are many irrationally priced stocks that are using up my margin.

Interesting for philosophers of science is that I think some of EXAS President's
analsysis is wrong because there are methodological problems with the Von Mises
sampling definition of probability everybody assumes. It is not true that
two 90% tests produce higher than 90% chance of cancer detection. It is
true that tests every few years is positive because polyps grow.
 
Quote from stock777:

is this another thread where folks show a fancy way to lose money?

Beats me. I sold 10 Apr $6 puts for 40 cents a month ago and bought 'em back on Monday for 25 cents. Booked a smooth $123.44 after commissions and fees.

Drinks are on me, boys. :D
 
Quote from jimmyjazz:

Beats me. I sold 10 Apr $6 puts for 40 cents a month ago and bought 'em back on Monday for 25 cents. Booked a smooth $123.44 after commissions and fees.

Drinks are on me, boys. :D

I could use a whiskey today.
 
Quote from newwurldmn:

I could use a whiskey today.


Yeah, I hear you. I'm in Austin, barely 90 minutes from West, which has been partially blown off the map. It seems half our trauma personnel are up there.
 
Back
Top